What is he best known for?
The fields of study he is best known for:
- Gene
- Neuron
- Internal medicine
Alan R. Harvey focuses on Neuroscience, Cell biology, Optic nerve, Retinal ganglion and Anatomy.
His work on Superior colliculus and Hippocampus as part of general Neuroscience research is frequently linked to Diffusion Anisotropy and Tortuosity, thereby connecting diverse disciplines of science.
His Cell biology study combines topics in areas such as Controlled release, Nanoparticle, Immunology and Vesicle.
His primary area of study in Optic nerve is in the field of Retinal ganglion cell.
The concepts of his Retinal ganglion cell study are interwoven with issues in Axotomy, Ciliary neurotrophic factor and Pathology.
Alan R. Harvey interconnects Astrocyte, Transplantation and Brainstem in the investigation of issues within Anatomy.
His most cited work include:
- Macrophage-Derived Factors Stimulate Optic Nerve Regeneration (416 citations)
- Intraocular elevation of cyclic AMP potentiates ciliary neurotrophic factor-induced regeneration of adult rat retinal ganglion cell axons. (228 citations)
- AAV-mediated expression of CNTF promotes long-term survival and regeneration of adult rat retinal ganglion cells (213 citations)
What are the main themes of his work throughout his whole career to date?
His scientific interests lie mostly in Neuroscience, Anatomy, Pathology, Retina and Cell biology.
His Neuroscience study frequently links to other fields, such as Regeneration.
The various areas that Alan R. Harvey examines in his Anatomy study include Neuropil, Retinal, Lesion and Transplantation.
Retina is represented through his Retinal ganglion cell, Retinal ganglion and Visual system research.
His Retinal ganglion cell research is multidisciplinary, incorporating elements of Endocrinology, Axon, Ciliary neurotrophic factor and Internal medicine.
Many of his studies on Cell biology apply to Immunology as well.
He most often published in these fields:
- Neuroscience (28.79%)
- Anatomy (24.90%)
- Pathology (20.62%)
What were the highlights of his more recent work (between 2014-2021)?
- Neuroscience (28.79%)
- Cell biology (19.07%)
- Retinal ganglion (16.34%)
In recent papers he was focusing on the following fields of study:
His primary areas of study are Neuroscience, Cell biology, Retinal ganglion, Biophysics and Neurotrophic factors.
His Axon and Regeneration investigations are all subjects of Cell biology research.
His Retinal ganglion study integrates concerns from other disciplines, such as Retinal ganglion cell and Programmed cell death.
Optic nerve covers he research in Retinal ganglion cell.
In his research, Glial cell line-derived neurotrophic factor is intimately related to Neurotrophin, which falls under the overarching field of Neurotrophic factors.
His Anatomy research includes themes of Resistance training and Pathology.
Between 2014 and 2021, his most popular works were:
- The Acquisition of Target Dependence by Developing Rat Retinal Ganglion Cells (90 citations)
- Functional dissection of NEAT1 using genome editing reveals substantial localization of the NEAT1_1 isoform outside paraspeckles (67 citations)
- Neurotrophic factors for spinal cord repair: Which, where, how and when to apply, and for what period of time? (53 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Neuron
- Internal medicine
His main research concerns Neuroscience, Retinal ganglion, Neurotrophic factors, Ciliary neurotrophic factor and Axon.
His Neuroscience study combines topics from a wide range of disciplines, such as Ion channel and Anatomy.
His Retinal ganglion study introduces a deeper knowledge of Retina.
His Ciliary neurotrophic factor research incorporates themes from Molecular biology and Retinal ganglion cell.
His work deals with themes such as Gene expression and Regeneration, which intersect with Retinal ganglion cell.
His Axon research is included under the broader classification of Cell biology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
